Company intelligence / Profile preview

Hefei Yigong Pharmaceutical

Hefei, Anhui, China
Ownership
Private
Development stage
Other
01

Overview

Reported involvement in preclinical research on novel colchicine derivatives through collaboration with China Pharmaceutical University for inflammatory and related diseases.

Therapeutic areas
ImmunologyRheumatologyOncology
Modalities
Small molecule
Industry
Academic Hospital/University/Research
02

Partnerships

China Pharmaceutical University

Beyond the preview

Go deeper on Hefei Yigong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hefei Yigong Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call